These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10701688)

  • 1. Cardiac dysfunction occurs in the HIV-1 transgenic mouse treated with zidovudine.
    Lewis W; Grupp IL; Grupp G; Hoit B; Morris R; Samarel AM; Bruggeman L; Klotman P
    Lab Invest; 2000 Feb; 80(2):187-97. PubMed ID: 10701688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined antiretroviral therapy causes cardiomyopathy and elevates plasma lactate in transgenic AIDS mice.
    Lewis W; Haase CP; Raidel SM; Russ RB; Sutliff RL; Hoit BD; Samarel AM
    Lab Invest; 2001 Nov; 81(11):1527-36. PubMed ID: 11706060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic mitochondrial superoxide dismutase and mitochondrially targeted catalase prevent antiretroviral-induced oxidative stress and cardiomyopathy.
    Kohler JJ; Cucoranu I; Fields E; Green E; He S; Hoying A; Russ R; Abuin A; Johnson D; Hosseini SH; Raper CM; Lewis W
    Lab Invest; 2009 Jul; 89(7):782-90. PubMed ID: 19398959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial Fas ligand expression increases susceptibility to AZT-induced cardiomyopathy.
    Purevjav E; Nelson DP; Varela JJ; Jimenez S; Kearney DL; Sanchez XV; DeFreitas G; Carabello B; Taylor MD; Vatta M; Shearer WT; Towbin JA; Bowles NE
    Cardiovasc Toxicol; 2007; 7(4):255-63. PubMed ID: 17943461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic mouse model with deficient mitochondrial polymerase exhibits reduced state IV respiration and enhanced cardiac fibrosis.
    Koczor CA; Torres RA; Fields E; Qin Q; Park J; Ludaway T; Russ R; Lewis W
    Lab Invest; 2013 Feb; 93(2):151-8. PubMed ID: 23090637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus.
    Domanski MJ; Sloas MM; Follmann DA; Scalise PP; Tucker EE; Egan D; Pizzo PA
    J Pediatr; 1995 Jul; 127(1):137-46. PubMed ID: 7608800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of zidovudine compared to stavudine, both in combination with lamivudine and indinavir, in human immunodeficiency virus-infected nucleoside-experienced patients with no prior exposure to lamivudine, stavudine, or protease inhibitors (novavir trial).
    Joly V; Flandre P; Meiffredy V; Brun-Vezinet F; Gastaut JA; Goujard C; Remy G; Descamps D; Ruffault A; Certain A; Aboulker JP; Yeni P;
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1906-13. PubMed ID: 12019107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine cardiac mtDNA: effects of transgenic manipulation of nucleoside phosphorylation.
    Kohler JJ; Hosseini SH; Cucoranu I; Hoying-Brandt A; Green E; Johnson D; Wittich B; Srivastava J; Ivey K; Fields E; Russ R; Raper CM; Santoianni R; Lewis W
    Lab Invest; 2009 Feb; 89(2):122-30. PubMed ID: 19079325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic expression of the deoxynucleotide carrier causes mitochondrial damage that is enhanced by NRTIs for AIDS.
    Lewis W; Haase CP; Miller YK; Ferguson B; Stuart T; Ludaway T; McNaught J; Russ R; Steltzer J; Santoianni R; Long R; Fiermonte G; Palmieri F
    Lab Invest; 2005 Aug; 85(8):972-81. PubMed ID: 15951836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical analysis of the pharmacology of AZT and its use in AIDS.
    Papadopulos-Eleopulos E; Turner VF; Papadimitriou JM; Causer D; Alphonso H; Miller T
    Curr Med Res Opin; 1999; 15 Suppl 1():S1-45. PubMed ID: 11594171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis.
    Lewis W; Kohler JJ; Hosseini SH; Haase CP; Copeland WC; Bienstock RJ; Ludaway T; McNaught J; Russ R; Stuart T; Santoianni R
    AIDS; 2006 Mar; 20(5):675-84. PubMed ID: 16514297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy.
    Sievers M; Walker UA; Sevastianova K; Setzer B; Wågsäter D; Eriksson P; Yki-Järvinen H; Sutinen J
    J Infect Dis; 2009 Jul; 200(2):252-62. PubMed ID: 19519254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic cardiac-targeted overexpression of human thymidylate kinase.
    Kohler JJ; Hosseini SH; Cucoranu I; Zhelyabovska O; Green E; Ivey K; Abuin A; Fields E; Hoying A; Russ R; Santoianni R; Raper CM; Yang Q; Lavie A; Lewis W
    Lab Invest; 2010 Mar; 90(3):383-90. PubMed ID: 20065942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of reactive oxygen species and poly-ADP-ribose polymerase in the development of AZT-induced cardiomyopathy in rat.
    Szabados E; Fischer GM; Toth K; Csete B; Nemeti B; Trombitas K; Habon T; Endrei D; Sumegi B
    Free Radic Biol Med; 1999 Feb; 26(3-4):309-17. PubMed ID: 9895221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3'-Azido-3'-deoxythymidine ameliorates the thrombocytopenia observed in a murine model of AIDS.
    Chow FP; Sutton PA; Hamburger AW
    Exp Hematol; 1990 Oct; 18(9):1038-41. PubMed ID: 2168839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidences that zidovudine (AZT) could not be directly responsible for iron overload in AZT-treated patients: an in vitro study.
    D'Alessandro AM; Rinaldi AC; D'Andrea G; Brisdelli F; Di Ciccio L; Di Giulio A; Oratore A; Bozzi A
    Clin Chim Acta; 2000 Oct; 300(1-2):119-30. PubMed ID: 10958868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals.
    Spaulding A; Rutherford GW; Siegfried N
    Cochrane Database Syst Rev; 2010 Oct; (10):CD008740. PubMed ID: 20927777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocaine increases mortality and cardiac mass in a murine transgenic model of acquired immune deficiency syndrome.
    Sutliff RL; Haase C; Russ R; Hoit BD; Morris R; Norman AB; Lewis W
    Lab Invest; 2003 Jul; 83(7):983-9. PubMed ID: 12861038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pol mutations conferring zidovudine and didanosine resistance with different effects in vitro yield multiply resistant human immunodeficiency virus type 1 isolates in vivo.
    Eron JJ; Chow YK; Caliendo AM; Videler J; Devore KM; Cooley TP; Liebman HA; Kaplan JC; Hirsch MS; D'Aquila RT
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1480-7. PubMed ID: 7689822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible zidovudine-induced pure red cell aplasia.
    Blanche P; Silberman B; Barreto L; Gombert B; Sicard D
    AIDS; 1999 Aug; 13(12):1586-7. PubMed ID: 10465087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.